Accumulating evidence suggests that SCFAs intervene in the development of T2DM in the stimulation of the peptide YY (PYY) and glucagon-like peptide-1 (GLP-1) secretion by colonocytes, which helps regulate host satiety and insulin secretion [34,35]. The gene discussed is INS; the disease is type 2 diabetes mellitus.